General

Cabotegravir/Rilpivirine: 96-Week HIV Treatment Results in Africa

by

Long-Acting HIV Treatment Shows Promise for Expanded Access in Africa Groundbreaking research indicates that a long-acting injectable therapy for HIV remains highly effective over an extended period, offering a potential game-changer for treatment access, particularly in African nations. The findings, stemming from a 96-week follow-up study, demonstrate that cabotegravir and rilpivirine, administered as an injection, … Read more

Flu Risk: Improved Models for Better Influenza A Insights

by

Influenza Risk in Raw Dairy: Ferret Study Advances Public Health Assessments Public health officials are gaining a more precise understanding of the risks associated with consuming raw milk and cheese potentially contaminated with influenza A virus, thanks to groundbreaking research utilizing a refined animal model. The study, published today, significantly expands the application of the … Read more

Gaza Preschoolers Face Malnutrition Crisis: Urgent Help Needed

by

Gaza’s Children Face Severe Malnutrition Crisis: Over 50,000 Preschoolers at Risk A newly released, month-by-month analysis paints a harrowing picture of the escalating malnutrition crisis among preschool-aged children in Gaza. The report reveals a direct correlation between restricted aid access, ongoing conflict, and a dramatic surge in severe malnutrition cases, with current estimates exceeding 50,000 … Read more

Transgender Hormone Therapy: Plasma Proteome Changes

by

Significant Protein Shifts Observed During Gender-Affirming Hormone Therapy Groundbreaking research has revealed substantial alterations in the protein composition of blood plasma among individuals undergoing feminizing gender-affirming hormone therapy. A new study, detailed in Nature Medicine, identifies nearly 300 proteins that experience significant changes over a six-month period, potentially impacting long-term health outcomes. Understanding the Biological … Read more

SARS-CoV-2 DNA Antibody Safety & PK in Adults – Phase 1

by

Promising New Approach to COVID-19 Protection: Intramuscular Antibody Delivery Shows Safety in Early Trials In a significant step forward in the ongoing fight against COVID-19, a phase 1 clinical trial has demonstrated the safety and tolerability of a novel approach to delivering protective antibodies directly into the body. Researchers have successfully tested intramuscular injections of … Read more

India: Older Adults & Cardiometabolic Disease Risk

by

India’s Silent Epidemic: How Cardiometabolic Multimorbidity Will Reshape Healthcare by 2030 Over 55 million Indians are living with multiple chronic conditions simultaneously – a figure projected to surge past 80 million within the next decade. This isn’t simply about aging populations; it’s a crisis fueled by poverty, lifestyle shifts, and a healthcare system struggling to … Read more

Alzheimer’s: Quick Cognitive Test Boosts Early Detection

by

New Digital Test Dramatically Improves Alzheimer’s Diagnosis Accuracy A groundbreaking new assessment tool, BioCog, is poised to revolutionize the early detection of cognitive decline, offering hope for more timely and effective interventions for individuals at risk of neurodegenerative diseases like Alzheimer’s. The innovative digital test battery, designed for brief self-administration in primary care settings, has … Read more

Domvanalimab & Zimberelimab: Gastric/Esophageal Cancer Trial

by

Promising New Drug Combination Shows Benefit in Advanced Cancers In a significant development for cancer treatment, a novel combination therapy is demonstrating encouraging results in patients battling advanced gastric, gastroesophageal junction, and esophageal cancers. The treatment regimen, featuring domvanalimab and zimberelimab alongside standard FOLFOX chemotherapy, was presented at the ESMO Congress 2025 and detailed in … Read more

Pancreatic Cancer: AI & Multimodal Care for Chemo Support

by

Beyond Chemotherapy: How AI-Powered Multimodal Care is Redefining Pancreatic Cancer Treatment Pancreatic cancer, even in its early stages, carries a grim prognosis. But a new wave of research, exemplified by the European multicenter RELEV trial investigating digital and AI-assisted multimodal supportive care, suggests a paradigm shift is underway. While current treatments focus heavily on chemotherapy, … Read more

Nivolumab & Relatlimab: Melanoma Stage III/IV Trial Results

by

Melanoma Treatment Combination Shows No Significant Survival Benefit in Late-Stage Trials Recent findings from the RELATIVITY-098 trial, presented at both the ASCO 2025 Annual Meeting and the ESMO Congress 2025, indicate that adding relatlimab to nivolumab does not significantly improve recurrence-free survival in patients with stage III or IV resected melanoma. This news represents a … Read more

© 2026 Archyworldys. All rights reserved.

For contact, advertising, copyright, issues email: [email protected]